On the upside
The Food and Drug Administration conditionally approved XTENT's (Nasdaq: XTNT) application to begin clinical trials for its drug eluting stent system.
Somaxon Pharmaceuticals (Nasdaq: SOMX) resubmitted its application to the Food and Drug Administration for its insomnia treatment Silenor with additional statistical analyses.
The Food and Drug Administration approved Palomar Medical Technologies' (Nasdaq: PMTI) at-home laser system to treat eye wrinkles.
On the downside
Exide Technologies (Nasdaq: XIDE) blamed lower prices and one time charges for swinging to a fourth quarter loss.Cal Dive International's (NYSE: DVR) majority shareholder Helix Energy (NYSE: HLX) will sell 20 million on its shares at a 5% discount to the offshore energy services firm closing price yesterday.
United PanAm Financial (Nasdaq: UPFC) will voluntarily delist its stock from Nasdaq and deregister its stock.
In the broad market, advancing issues outpaced decliners by a margin of 7 to 5 on the NYSE while decliners barely edged out advancers by a slim margin on Nasdaq. The Russell 2000 which tracks small cap stocks added a point to 533.
